Integral Diagnostics Limited (ASX:IDX)
2.330
0.00 (0.00%)
Aug 27, 2026, 4:10 PM AEST
Integral Diagnostics Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 868 | 745 | 945 | 625 | 764 | 694 | |
Market Cap Growth | -23.55% | -21.20% | 51.38% | -18.29% | 10.12% | -32.80% |
Enterprise Value | 1,419 | 1,316 | 1,447 | 968 | 1,092 | 989 |
Last Close Price | 2.27 | 1.95 | 2.41 | 2.47 | 2.97 | 2.69 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 40.17 | 33.97 | 351.59 | - | 30.53 | 47.53 |
Forward PE | 17.39 | 13.77 | 20.32 | 27.67 | 25.99 | 17.42 |
PS Ratio | 1.10 | 0.95 | 1.51 | 1.33 | 1.73 | 1.92 |
PB Ratio | 1.27 | 1.09 | 1.37 | 2.07 | 2.05 | 2.00 |
P/FCF Ratio | 19.03 | 16.34 | 67.47 | 14.77 | 32.83 | 74.39 |
P/OCF Ratio | 9.11 | 7.82 | 12.82 | 9.44 | 11.36 | 18.71 |
PEG Ratio | 0.33 | 0.44 | 0.74 | 3.58 | 1.09 | 2.12 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 1.80 | 1.67 | 2.31 | 2.06 | 2.48 | 2.74 |
EV/EBITDA Ratio | 10.06 | 11.71 | 16.50 | 14.62 | 16.53 | 15.89 |
EV/EBIT Ratio | 19.22 | 17.82 | 25.47 | 22.96 | 28.40 | 25.60 |
EV/FCF Ratio | 31.12 | 28.85 | 103.25 | 22.90 | 46.92 | 105.99 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.88 | 0.88 | 0.85 | 1.19 | 0.98 | 0.98 |
Debt / EBITDA Ratio | 4.23 | 4.23 | 5.32 | 4.27 | 4.45 | 4.53 |
Debt / FCF Ratio | 13.09 | 13.09 | 41.75 | 8.46 | 15.68 | 36.55 |
Net Debt / Equity Ratio | 0.80 | 0.80 | 0.77 | 1.05 | 0.89 | 0.63 |
Net Debt / EBITDA Ratio | 4.86 | 4.86 | 6.08 | 4.76 | 5.01 | 3.50 |
Net Debt / FCF Ratio | 11.97 | 11.97 | 38.03 | 7.46 | 14.23 | 23.34 |
Asset Turnover | 0.55 | 0.55 | 0.58 | 0.60 | 0.55 | 0.50 |
Inventory Turnover | 183.62 | 183.62 | 206.83 | 181.65 | 191.73 | 219.31 |
Quick Ratio | 0.59 | 0.59 | 0.59 | 0.81 | 0.70 | 1.84 |
Current Ratio | 0.67 | 0.67 | 0.67 | 0.87 | 0.76 | 1.93 |
Return on Equity (ROE) | 3.21% | 3.21% | 0.57% | -17.99% | 6.95% | 4.85% |
Return on Assets (ROA) | 3.24% | 3.24% | 3.27% | 3.36% | 2.99% | 3.36% |
Return on Invested Capital (ROIC) | 4.13% | 4.13% | 1.98% | 6.38% | 4.95% | 4.69% |
Return on Capital Employed (ROCE) | 5.80% | 5.80% | 4.40% | 6.40% | 5.20% | 5.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 2.53% | 2.94% | 0.28% | -9.72% | 3.28% | 2.10% |
FCF Yield | 5.25% | 6.12% | 1.48% | 6.77% | 3.05% | 1.34% |
Dividend Yield | 3.99% | 4.77% | 2.70% | 2.35% | 2.02% | 2.60% |
Payout Ratio | 118.21% | 118.21% | 574.82% | - | 50.48% | 142.87% |
Buyback Yield / Dilution | -21.41% | -21.40% | -32.86% | 0.97% | -11.29% | -5.70% |
Total Shareholder Return | -17.41% | -16.63% | -30.16% | 3.32% | -9.27% | -3.10% |